Literature DB >> 6591377

Endoscopic biliary drainage.

M Classen, F Hagenmüller.   

Abstract

Endoscopic drainage of the occluded biliary system through the papilla Vateri consists of two different methods, i.e. bilio- nasal and bilio-duodenal drainage. For bilio-nasal drainage a 250-cm- long preformed polyethylene tube is placed above the stenosis to provide the flow out of the congested bile duct. This external drainage is indicated to prevent the blockade of a ductal stone after endoscopic papillotomy (EPT), to treat septic cholangitis, and to dissolve big ductal stones chemically. Insertion of a bilio-nasal probe succeeds in 95% of hte cases. Internal bilio-duodenal drainage is more difficult and succeeds in 87%, its main indication is the inoperable malignant bile duct obstruction. The value of a preoperative biliary drainage is in discussion. Internal bilio-duodenal drainage will perhaps not prolong the survival time of patients with malignant biliary obstruction but it will improve the life quality in the majority of the patients. The decrease of serum bilirubin after the implantation of the prosthesis and the localization of the tumor are of prognostic significance.

Entities:  

Mesh:

Year:  1984        PMID: 6591377

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  3 in total

1.  Tissue sampling from the common bile duct through endoscopic retrograde cholangiopancreatography, endoscopic papillo(sphinctero)tomy and drainage in juxtapapillary malignancies.

Authors:  V Pugliese; D Barone; S Saccomanno; M Conio; H Aste; L Santi
Journal:  Surg Endosc       Date:  1987       Impact factor: 4.584

2.  Nasobiliary drainage following endoscopic sphincterotomy. A useful method of preventing and treating early complications.

Authors:  E Ricci; R Conigliaro; G Bertoni; M G Mortilla; G Bedogni; S Contini
Journal:  Surg Endosc       Date:  1987       Impact factor: 4.584

Review 3.  Endoscopic drainage in patients with inoperable hilar cholangiocarcinoma.

Authors:  Ye Jin Park; Dae Hwan Kang
Journal:  Korean J Intern Med       Date:  2012-12-28       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.